Humanwell Healthcare (Group) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000QW6
CNY
18.74
-0.47 (-2.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
5,864.49
6,083.60
6,274.76
6,225.42
6,440.81
6,316.19
6,345.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,864.49
6,083.60
6,274.76
6,225.42
6,440.81
6,316.19
6,345.88
Raw Material Cost
3,229.22
3,292.53
4,075.52
3,512.22
3,551.38
3,532.48
3,585.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
74.02
80.92
81.45
91.22
93.49
85.20
86.48
Selling and Distribution Expenses
1,325.44
1,557.37
1,791.63
1,437.10
1,549.62
1,617.22
1,615.90
Other Expenses
23.40
30.13
26.66
26.70
23.34
23.45
34.61
Total Expenditure (Excl Depreciation)
4,862.71
5,232.15
6,215.25
5,307.54
5,427.86
5,469.40
5,634.00
Operating Profit (PBDIT) excl Other Income
1001.8000000000001
851.4
59.5
917.9000000000001
1013
846.8000000000001
711.9
Other Income
37.03
32.89
106.20
-25.15
35.78
33.21
36.69
Operating Profit (PBDIT)
1,277.23
1,143.50
55.84
1,172.26
1,285.47
1,122.74
963.11
Interest
74.02
80.92
81.45
91.22
93.49
85.20
86.48
Exceptional Items
-0.77
-0.85
119.98
-1.60
0.88
-6.54
6.69
Gross Profit (PBDT)
2,635.27
2,791.06
2,199.23
2,713.20
2,889.43
2,783.71
2,760.31
Depreciation
257.83
257.83
279.74
279.74
241.75
241.75
221.05
Profit Before Tax
944.60
803.90
-185.38
799.70
951.09
789.25
662.27
Tax
163.22
128.83
162.88
161.76
158.50
161.34
144.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
614.32
540.35
-259.95
478.60
624.70
486.39
365.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
614.32
540.35
-259.95
478.60
624.70
486.39
365.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
184.24
158.27
-69.09
173.15
182.74
161.80
166.34
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
798.56
698.62
-329.04
651.75
807.44
648.19
532.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
18,335.04
18,134.58
17,623.82
17,868.50
17,290.33
17,503.82
17,043.60
Earnings per share (EPS)
0.38
0.33
-0.16
0.29
0.38
0.3
0.22
Diluted Earnings per share
0.38
0.33
-0.16
0.29
0.38
0.3
0.22
Operating Profit Margin (Excl OI)
16.75%
14.02%
-5.26%
14.74%
15.65%
13.42%
11.12%
Gross Profit Margin
20.5%
17.45%
1.5%
17.34%
18.52%
16.32%
13.92%
PAT Margin
10.48%
8.88%
-4.14%
7.69%
9.7%
7.7%
5.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is -8.95% vs 5.42% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -1.09% vs -2.68% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -0.76% vs 19.52% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -20.86% vs 18.06% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Humanwell Healthcare (Group) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
5,864.49
0
5,864.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,864.49
0
5,864.49
Raw Material Cost
3,229.22
0
3,229.22
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
74.02
0
74.02
Selling and Distribution Expenses
1,325.44
0
1,325.44
Other Expenses
23.40
0.00
23.40
Total Expenditure (Excl Depreciation)
4,862.71
0
4,862.71
Operating Profit (PBDIT) excl Other Income
1,001.77
0.00
1,001.77
Other Income
37.03
0
37.03
Operating Profit (PBDIT)
1,277.23
0
1,277.23
Interest
74.02
0
74.02
Exceptional Items
-0.77
0
-0.77
Gross Profit (PBDT)
2,635.27
0
2,635.27
Depreciation
257.83
0
257.83
Profit Before Tax
944.60
0
944.60
Tax
163.22
0
163.22
Provisions and contingencies
0
0
0.00
Profit After Tax
614.32
0
614.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
614.32
0
614.32
Share in Profit of Associates
0
0
0.00
Minority Interest
184.24
0
184.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
798.56
0
798.56
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
18,335.04
0
18,335.04
Earnings per share (EPS)
0.38
0
0.38
Diluted Earnings per share
0.38
0
0.38
Operating Profit Margin (Excl OI)
16.75%
0%
0.00
16.75%
Gross Profit Margin
20.50%
0%
0.00
20.50%
PAT Margin
10.48%
0%
0.00
10.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 586.45 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -3.60% vs -3.05% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -8.95% vs 5.42% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 79.86 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 14.31% vs 312.34% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -1.09% vs -2.68% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 124.02 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.67% vs 2,303.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -0.76% vs 19.52% in Jun 2024

Quarterly - Interest
Interest 7.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -8.53% vs -0.74% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -20.86% vs 18.06% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.75%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024